N (%) or mean±SD N (%) or mean±SD
Female Female 87 (87%)
Age, years Age, years 48.9 ±12.2
Disease duration, years Disease duration, years 2,1 ±1.4
mRSS mRSS 10.8 ±10.4
Disease classification Disease classification
Diffuse 36 (36%)
Limited 63 (63%)
Sine scleroderma 1 (1%)
PAH PAH 3 (3%)
ILD ILD 33 (33%)
GIS GIS 60 (60%)
DU DU 14 (14%)
SRC SRC 0
Myositis Myositis 0
Malignancy Malignancy 3 (3%)
Overlap Overlap 23 (23%)
Anti-nuclear antibody profile Anti-nuclear antibody profile 93 (93%)
Staining ANA pattern Staining ANA pattern
Speckled 65 (65%)
Nucleolar 13 (13%)
Centromere 29 (29%)
Homogeneous 3 (3%)
Reticular 3 (3%)
Staining SSc profile pattern Staining SSc profile pattern
Scl 70 41 (41%)
ACA 27 (27%)
CENPA 27 (27%)
CENPB 26 (26%)
RNAPIII 15 (15%)
RNAP11 9 (9%)
RNAP155 13 (13%)
NOR90 2 (2%)
Th/To 1 (1%)
PM/Scl 75 8 (8%)
PM/Scl 100 5 (5%)
Ku 6 (6%)
Ro52 22 (22%)
Fibrillarin 0
Anti-PDGF 0